Hostname: page-component-745bb68f8f-b95js Total loading time: 0 Render date: 2025-02-02T22:26:02.927Z Has data issue: false hasContentIssue false
  • English
  • Français

Effect of ECT on the Neuroendocrine Response to Apomorphine in Severely Depressed Patients

Published online by Cambridge University Press:  29 January 2018

Janice E. Christie ,
L. J. Whalley ,
N. S. Brown  and
H. Dick
Janice E. Christie
Affiliation:
MRC Brain Metabolism Unit, Thomas Clouston Clinic, 153 Morningside Drive, Edinburgh
L. J. Whalley
Affiliation:
MRC Brain Metabolism Unit, Thomas Clouston Clinic
N. S. Brown
Affiliation:
Immunoassay Section, Department of Clinical Chemistry, Royal Infirmary, Edinburgh
H. Dick
Affiliation:
MRC Brain Metabolism Unit, University Department of Pharmacology, 1 George Square, Edinburgh
Get access Rights & Permissions [Opens in a new window]

Summary

Animal studies have suggested that the mechanism of the antidepressant action of ECT may be to increase monoaminergic post-synaptic receptor sensitivity. We have tested this hypothesis in 12 drug-free patients suffering from severe depression, 11 of whom had depressive delusions. The responses of growth hormone, prolactin and Cortisol to 0.75 mg subcutaneous apomorphine were examined before and after a successful course of ECT. There were no significant differences between hormonal measurements on the two occasions, with the exception that basal plasma Cortisol concentrations were significantly lower following ECT and recovery from depressive illness. These results do not support the hypothesis that ECT increases dopaminergic post-synaptic receptor sensitivity.

Type
Research Article
Information
The British Journal of Psychiatry , Volume 140 , Issue 3 , March 1982 , pp. 268 - 273
Copyright
Copyright © Royal College of Psychiatrists, 1982 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

Abrams, R. (1974) Multiple ECT—what have we learned? In Psychobiology of Convulsive Therapy (eds. Fink, M., Kety, S. S., McGaug, J. L. and Williams, T. A.), pp 79–85. New York: Wiley.Google Scholar
Brown, G. M., Seggie, J. A., Chambers, J. W. & Ettigi, P. G. (1978) Psychoendocrinology and growth hormone: A review. Psychoneuroendocrinology, 3, 131–53.CrossRefGoogle ScholarPubMed
Brown, W. A., Kreiger, D. T., Van Woert, M. H. & Ambani, L. M. (1974) Dissociation of growth hormone and Cortisol release following apomorphine. Journal of Clinical Endocrinology and Metabolism, 38, 1127–30.CrossRefGoogle ScholarPubMed
Carroll, B. J., Curtis, G. C. & Mendels, J. (1976) Neuroendocrine regulation in depression: 1. Limbic system—adrenocortical dysfunction. Archives of General Psychiatry, 33, 1039–44.CrossRefGoogle Scholar
Caspar, R. C., Davis, J. M., Pandey, G. N., Garver, D. L. & Dekirmenjian, H. (1977) Neuroendocrine and amine studies in affective illness. Psychoneuroendocrinology, 2, 105–14.Google Scholar
Checkley, S. A. & Meldrum, B. S. (1981) Studies on the mechanism of the antidepressant action of ECT. In Neuropeptides—Basic and Clinical Aspects (eds. Fink, G. and Whalley, L. J.). Edinburgh: Churchill Livingstone. (In press).Google Scholar
Checkley, S. A., Slade, A. P. & Shur, E. (1981) Growth hormone and other responses to clonidine in patients with endogenous depression. British Journal of Psychiatry, 138, 46–51.CrossRefGoogle ScholarPubMed
Costain, D. W., Grahame-Smith, D. G. & Green, A. R. (1978) Relevance of the enhanced 5-hydroxytryptamine behavioural responses in rats to electroconvulsive therapy. British Journal of Pharmacology and Chemotherapy, 56, 193–9.Google Scholar
Eden, S. & Modigh, K. (1977) Effects of apomorphine and clonidine on rat plasma growth hormone after pretreatment with reserpine and electroconvulsive shocks. Brain Research, 129, 379–84.CrossRefGoogle ScholarPubMed
Evans, J., Grahame-Smith, D. G., Green, A. R. & Tor-doff, A. F. C. (1976) Electroconvulsive shock increases the behavioural responses of rats to brain 5-hydroxytryptamine accumulation and central nervous system stimulant drugs. British Journal of Pharmacology and Chemotherapy, 56, 193–9.Google ScholarPubMed
Frazer, A. (1975) Adrenergic responses in depression: Implications for a receptor deficit. In Biological Psychiatry (ed. Mendels, J.), pp 7–26. New York: Wiley.Google Scholar
Grahame-Smith, D. G., Green, A. R. & Costain, D. W. (1978) Mechanisms of the antidepressant action of electroconvulsive therapy. Lancet, i, 244–56.Google Scholar
Hamilton, M. (1960) A rating scale for depression. Journal of Neurology, Neurosurgery and Psychiatry, 23, 56–62.CrossRefGoogle ScholarPubMed
Langer, G., Heinze, C., Reim, B. & Matussek, N. (1976) Reduced growth hormone responses to amphetamine in endogenous depressive patients. Archives of General Psychiatry, 33, 1471–5.CrossRefGoogle ScholarPubMed
Martin, J. B., Brazeau, P., Tannenbaum, G. S., Willoughby, J. O., Epelbaum, J., Terry, L. C. & Durand, D. (1978) Neuroendocrine organisation of growth hormone regulation. In The Hypothalamus (eds. Reichlin, S., Baldessarini, R. J. and Martin, J. B.), pp 329–55. New York: Raven Press.Google Scholar
Matussek, N. (1978) Neuroendokrinologische Untersuchungen bei depressiven Syndromen. Der Nervenarzt, 49, 569–75.Google Scholar
Modigh, K. (1975) Electroconvulsive shock and post-synaptic catecholamine effects: Increased psychomotor stimulant action of apomorphine and clonidine in reserpine pretreated mice by repeated ECS. Journal of Neural Transmission, 36, 19–32.CrossRefGoogle Scholar
Modigh, K., Balldin, J., Eden, S., Granerus, A.-K. & Walinder, J. (1981) Electroconvulsive therapy and receptor sensitivity. In Recent Advances in the Treatment of Depression (eds. Carlsson, A., Gottfries, C.-G., Holmberg, G., Modigh, K., Svensson, T. and Ogren, S.-O.). Acta Psychiatrica Scandinavica, Supplement 290, 63, 91–9.CrossRefGoogle Scholar
Sachar, E. J., Hellman, L., Gukushima, D. K. & Gallagher, T. F. (1970) Cortisol production in depressive illness: A clinical and biochemical clarification. Archives of General Psychiatry, 23, 289–98.CrossRefGoogle ScholarPubMed
Sachar, E. J., Finkelstein, J. & Hellman, L. (1971) Growth hormone responses in depressive illness: I. Responses to insulin tolerance test. Archives of General Psychiatry, 25, 263–9.CrossRefGoogle Scholar
Sachar, E. J., Frantz, A. B., Altman, N. & Sassin, J. (1973) Growth hormone prolactin in unipolar and bipolar depressed patients: Responses to hypoglycaemia and L-DOPA. American Journal of Psychiatry, 130, 1362–7.CrossRefGoogle ScholarPubMed
Slade, A. P. & Checkley, S. A. (1980) A neuroendocrine study of the mechanism of action of ECT. British Journal of Psychiatry, 137, 217–22.CrossRefGoogle ScholarPubMed
Spitzer, R. L., Endicott, J. & Robins, E. (1978) Research diagnostic criteria: Rationale and reliability. Archives of General Psychiatry, 36, 773–82.Google Scholar
Steiner, J. A. & Grahame-Smith, D. G. (1980) The effect of repeated electroconvulsive shocks on corticosterone responses to centrally acting pharmacological stimuli in the male rat. Psychopharmacology, 71, 205–12.CrossRefGoogle ScholarPubMed
Weiner, R. I. & Ganong, W. F. (1978) Role of brain monoamines and histamine in regulation of anterior pituitary secretion. Physiological Reviews, 58, 905–76.CrossRefGoogle ScholarPubMed
Submit a response

eLetters

No eLetters have been published for this article.